Privia Health Group, Inc. (NASDAQ:PRVA) COO Parth Mehrotra Sells 138,547 Shares

Privia Health Group, Inc. (NASDAQ:PRVAGet Rating) COO Parth Mehrotra sold 138,547 shares of the firm’s stock in a transaction dated Monday, September 19th. The shares were sold at an average price of $37.84, for a total transaction of $5,242,618.48. Following the sale, the chief operating officer now directly owns 97,391 shares in the company, valued at approximately $3,685,275.44. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Parth Mehrotra also recently made the following trade(s):

  • On Wednesday, July 20th, Parth Mehrotra sold 60,000 shares of Privia Health Group stock. The shares were sold at an average price of $34.06, for a total transaction of $2,043,600.00.
  • On Friday, July 15th, Parth Mehrotra sold 27,265 shares of Privia Health Group stock. The stock was sold at an average price of $34.78, for a total transaction of $948,276.70.
  • On Friday, July 8th, Parth Mehrotra sold 12,735 shares of Privia Health Group stock. The stock was sold at an average price of $34.23, for a total transaction of $435,919.05.
  • On Tuesday, July 5th, Parth Mehrotra sold 40,000 shares of Privia Health Group stock. The stock was sold at an average price of $29.93, for a total transaction of $1,197,200.00.

Privia Health Group Price Performance

Privia Health Group stock opened at $34.66 on Friday. The firm’s 50 day moving average price is $38.19 and its 200-day moving average price is $30.24. Privia Health Group, Inc. has a 1 year low of $17.99 and a 1 year high of $44.64. The stock has a market cap of $3.86 billion, a P/E ratio of -75.35 and a beta of 1.06.

Privia Health Group (NASDAQ:PRVAGet Rating) last announced its quarterly earnings results on Thursday, August 11th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.08). Privia Health Group had a negative return on equity of 9.44% and a negative net margin of 4.17%. The business had revenue of $335.54 million during the quarter, compared to the consensus estimate of $312.04 million. As a group, equities analysts expect that Privia Health Group, Inc. will post -0.26 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the stock. Cowen raised their price objective on shares of Privia Health Group from $35.00 to $44.00 and gave the stock an “outperform” rating in a report on Friday, August 12th. SVB Leerink raised their price objective on shares of Privia Health Group from $33.00 to $46.00 and gave the stock an “outperform” rating in a report on Friday, August 12th. Canaccord Genuity Group lifted their price target on shares of Privia Health Group from $45.00 to $50.00 and gave the company a “buy” rating in a report on Thursday, August 25th. Truist Financial lifted their price target on shares of Privia Health Group from $48.00 to $54.00 and gave the company a “buy” rating in a report on Wednesday, September 7th. Finally, Guggenheim lifted their price target on shares of Privia Health Group from $36.00 to $51.00 and gave the company a “buy” rating in a report on Friday, August 12th. Twelve analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $44.58.

Institutional Investors Weigh In On Privia Health Group

Several large investors have recently bought and sold shares of PRVA. Point72 Asset Management L.P. bought a new stake in Privia Health Group in the fourth quarter worth $42,442,000. BlackRock Inc. increased its position in Privia Health Group by 108.4% in the first quarter. BlackRock Inc. now owns 2,579,166 shares of the company’s stock worth $68,940,000 after purchasing an additional 1,341,730 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in Privia Health Group by 71.8% in the second quarter. Price T Rowe Associates Inc. MD now owns 2,780,204 shares of the company’s stock worth $80,960,000 after purchasing an additional 1,162,270 shares during the last quarter. Bank of New York Mellon Corp increased its position in Privia Health Group by 34.1% in the first quarter. Bank of New York Mellon Corp now owns 4,138,080 shares of the company’s stock worth $110,611,000 after purchasing an additional 1,052,856 shares during the last quarter. Finally, Macquarie Group Ltd. boosted its stake in Privia Health Group by 967.2% during the second quarter. Macquarie Group Ltd. now owns 799,353 shares of the company’s stock worth $23,277,000 after buying an additional 724,449 shares during the period. Institutional investors own 62.81% of the company’s stock.

About Privia Health Group

(Get Rating)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

Featured Stories

Insider Buying and Selling by Quarter for Privia Health Group (NASDAQ:PRVA)

Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.